3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Vulvar Diseases
1
Papillomavirus Infections
1
Interventions
fludarabine phosphate
1
fludarabine
1
artesunic acid
1
artenimol
1
artemisinin
1
aldesleukin
1
Respiratory Function Tests
1
Prochlorperazine
1
Positron-Emission Tomography
1
Ondansetron
1
O(6)-codeine methyl ether
1
Meperidine
1
Magnetic Resonance Imaging
1
Loperamide
1
Interleukin-2
1
Innovar
1
Indomethacin
1
Hydroxyzine
1
Granisetron
1
Electrocardiography
1
Droperidol
1
Doxylamine
1
Diphenoxylate
1
Diphenhydramine
1
Cyclophosphamide
1
Codeine
1
Cell Count
1
Biopsy
1
Atropine
1
Acetaminophen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Vulvar Diseases
×
artenimol
×
Gynecologic
×
Clear all
NCT06075264
2025-08-14
ART-VIN IIB
Frantz Viral Therapeutics, LLC
Phase 2
Recruiting
27 enrolled